Movatterモバイル変換


[0]ホーム

URL:


GB2098867B - Sustained release pharmaceutical composition - Google Patents

Sustained release pharmaceutical composition

Info

Publication number
GB2098867B
GB2098867BGB8214461AGB8214461AGB2098867BGB 2098867 BGB2098867 BGB 2098867BGB 8214461 AGB8214461 AGB 8214461AGB 8214461 AGB8214461 AGB 8214461AGB 2098867 BGB2098867 BGB 2098867B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
sustained release
release pharmaceutical
sustained
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8214461A
Other versions
GB2098867A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother LtdfiledCriticalJohn Wyeth and Brother Ltd
Priority to GB8214461ApriorityCriticalpatent/GB2098867B/en
Publication of GB2098867ApublicationCriticalpatent/GB2098867A/en
Application grantedgrantedCritical
Publication of GB2098867BpublicationCriticalpatent/GB2098867B/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

GB8214461A1981-05-211982-05-18Sustained release pharmaceutical compositionExpiredGB2098867B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
GB8214461AGB2098867B (en)1981-05-211982-05-18Sustained release pharmaceutical composition

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
GB81156781981-05-21
GB8214461AGB2098867B (en)1981-05-211982-05-18Sustained release pharmaceutical composition

Publications (2)

Publication NumberPublication Date
GB2098867A GB2098867A (en)1982-12-01
GB2098867Btrue GB2098867B (en)1984-10-24

Family

ID=26279556

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB8214461AExpiredGB2098867B (en)1981-05-211982-05-18Sustained release pharmaceutical composition

Country Status (1)

CountryLink
GB (1)GB2098867B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4540566A (en)*1984-04-021985-09-10Forest Laboratories, Inc.Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
GB2176999B (en)*1985-06-221989-07-12Stanley Stewart DavisSustained release medicament
SE450087B (en)*1985-10-111987-06-09Haessle Ab GRAINS WITH CONTROLLED RELEASE OF PHARMACIFICALLY ACTIVE SUBSTANCES APPLIED SIGNED ON A COMPACT INSULABLE NUCLEAR MATERIAL
SE455836B (en)*1985-10-111988-08-15Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
FR2620332A1 (en)*1987-09-111989-03-17Squibb & Sons Inc PHARMACEUTICAL COMPOSITION HAVING A HIGH MEDICINAL CONTENT, AND PROCESS FOR PREPARING THE SAME
US5049394A (en)*1987-09-111991-09-17E. R. Squibb & Sons, Inc.Pharmaceutical composition containing high drug load and method for preparing same
SE8703881D0 (en)*1987-10-081987-10-08Haessle Ab NEW PHARMACEUTICAL PREPARATION
US4971805A (en)*1987-12-231990-11-20Teysan Pharmaceuticals Co., Ltd.Slow-releasing granules and long acting mixed granules comprising the same
US4938968A (en)*1988-07-261990-07-03Norjec Development Associates, Inc.Controlled release indomethacin
US5133974A (en)*1989-05-051992-07-28Kv Pharmaceutical CompanyExtended release pharmaceutical formulations
US5122384A (en)*1989-05-051992-06-16Kv Pharmaceutical CompanyOral once-per-day organic nitrate formulation which does not induce tolerance
CA2936746C (en)2014-10-312017-06-27Purdue PharmaMethods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en)2018-11-192020-07-28Purdue Pharma L.P.Methods and compositions particularly for treatment of attention deficit disorder

Also Published As

Publication numberPublication date
GB2098867A (en)1982-12-01

Similar Documents

PublicationPublication DateTitle
GB2108841B (en)Sustained release layered pharmaceutical compositions
GB2053681B (en)Sustained release pharmaceutical composition
IL58279A0 (en)Sustained release pharmaceutical compositions
PH25637A (en)Dipyridamole-containing pharmaceutical form
GB2053682B (en)Sustained release pharmaceutical compositions
AR243378A1 (en)Sustained release pharmaceutical composition
AU557693B2 (en)Pharmaceutical sustained release compounds
ZA824622B (en)Pharmaceutical compositions
ZA834074B (en)Pharmaceutical composition
NZ201520A (en)Substituted aminopyridazines and pharmaceutical compositions
EP0093551A3 (en)Pharmaceutical composition
ZA825397B (en)Pharmaceutical compositions
SG21388G (en)Pharmaceutical formulations
JPS56103110A (en)Sustained release medicinal composition
GB2098867B (en)Sustained release pharmaceutical composition
ZA822856B (en)Pharmaceutical compositions
JPS57149230A (en)Medicinal composition
JPS57149222A (en)Granular medicinal composition
GB8329700D0 (en)Anti-haemophilic pharmaceutical composition
GB8328896D0 (en)Pharmaceutical composition
DE3278126D1 (en)Sustained release compositions
MY8700560A (en)Pharmaceutical compositions
ZA826479B (en)Pharmaceutical compositions
JPS57181007A (en)Local drug composition
GB8332653D0 (en)Pharmaceutical composition

Legal Events

DateCodeTitleDescription
PE20Patent expired after termination of 20 years

Effective date:20020517


[8]ページ先頭

©2009-2025 Movatter.jp